UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2951-2958

2014

Volltextzugriff (PDF)

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

The Lancet (British edition), 2011-01, Vol.377 (9762), p.321-331

2011

Volltextzugriff (PDF)

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1531-1538

2011

Volltextzugriff (PDF)

Compliance, Analgesic Use and Side-effect Protection within a German Cohort of the TEAM Trial

Anticancer research, 2012-09, Vol.32 (9), p.3933-3938

2012

Volltextzugriff (PDF)

Duration of Chemotherapy with Topotecan Influences Survival in Recurrent Ovarian Cancer: A Meta-analysis

Anticancer research, 2007-05, Vol.27 (3B), p.1581-1588

2007

Volltextzugriff (PDF)

Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (9), p.2348-2350

2000

Volltextzugriff (PDF)

Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion

Cancer research (Chicago, Ill.), 1995-07, Vol.55 (13), p.2743-2745

1995

Volltextzugriff (PDF)

Point Mutations in the Human Vitamin D Receptor Gene Associated with Hypocalcemic Rickets

Science (American Association for the Advancement of Science), 1988-12, Vol.242 (4886), p.1702-1705

1988

Volltextzugriff (PDF)

Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.524-524

2017

Volltextzugriff (PDF)

Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.505-505

2017

Volltextzugriff (PDF)

Abstract P4-11-05: Does androgen receptor (AR) expression impact on residual risk? A TEAM pathology study

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P4-P4-11-05

2015

Volltextzugriff (PDF)

Abstract S2-01: Theranostic multiparametric tests improve residual risk assessment in early luminal breast cancer

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.S2-S2-01

2015

Volltextzugriff (PDF)

Adenovirus-mediated Thymidine Kinase Gene Therapy and Coxsackie Adenovirus Receptor Expression in Ovarian Cancer Cells

Cancer genomics & proteomics, 2008-11, Vol.5 (6), p.311

Kieback, D G

2008

Volltextzugriff (PDF)

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix

Clinical cancer research, 1997-09, Vol.3 (9), p.1501-1505

1997

Volltextzugriff (PDF)

Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor

Cancer research (Chicago, Ill.), 1993-11, Vol.53 (21), p.5188-5192

1993

Volltextzugriff (PDF)

Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison

Anticancer research, 1999-05, Vol.19 (3B), p.2189

1999

Volltextzugriff (PDF)

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer

Anticancer research, 1999-09, Vol.19 (5C), p.4391

1999

Volltextzugriff (PDF)

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer

Anticancer research, 1999-05, Vol.19 (3B), p.2365

1999

Volltextzugriff (PDF)

Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment

Anticancer research, 1999-05, Vol.19 (3B), p.2163

1999

Volltextzugriff (PDF)

Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives

Anticancer research, 1997-03, Vol.17 (2A), p.815

1997

Volltextzugriff (PDF)

Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients

Anticancer research, 2001-01, Vol.21 (1B), p.697

2001

Volltextzugriff (PDF)

Comparative Evaluation of Seven Cell Collection Devices for Cervical Smears

Acta cytologica, 1999-11, Vol.43 (6), p.1023-1026

1999

Volltextzugriff (PDF)

Comparison of ID8 MOSE and VEGF-modified ID8 Cell Lines in an Immunocompetent Animal Model for Human Ovarian Cancer

Anticancer research, 2006-07, Vol.26 (4B), p.2785-2789

2006

Volltextzugriff (PDF)

Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter

Anticancer research, 2000-09, Vol.20 (5A), p.2811

2000

Volltextzugriff (PDF)

Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents

Anticancer research, 1998-09, Vol.18 (5A), p.3421

1998

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Anticancer Research
(19)
Cancer Research
(5)
Journal Of Clinical Oncology
(4)
Acta Cytologica
(1)
Cancer Epidemiology, Biomarkers & Prevention
(1)
Cancer Genomics & Proteomics
(1)
Clinical Cancer Research
(1)
Science
(1)
The Lancet
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

Compliance, Analgesic Use and Side-effect Protection within a German Cohort of the TEAM Trial

Duration of Chemotherapy with Topotecan Influences Survival in Recurrent Ovarian Cancer: A Meta-analysis

Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50

Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion

Point Mutations in the Human Vitamin D Receptor Gene Associated with Hypocalcemic Rickets

Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets

Abstract P4-11-05: Does androgen receptor (AR) expression impact on residual risk? A TEAM pathology study

Abstract S2-01: Theranostic multiparametric tests improve residual risk assessment in early luminal breast cancer

Adenovirus-mediated Thymidine Kinase Gene Therapy and Coxsackie Adenovirus Receptor Expression in Ovarian Cancer Cells

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix

Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor

Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer

Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment

Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives

Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients

Comparative Evaluation of Seven Cell Collection Devices for Cervical Smears

Comparison of ID8 MOSE and VEGF-modified ID8 Cell Lines in an Immunocompetent Animal Model for Human Ovarian Cancer

Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter

Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents

Aktive Filter

Suchergebnisse filtern